To include your compound in the COVID-19 Resource Center, submit it here.
Cell culture studies suggest inhibiting PRKCD, PKCE or RASGRP3 could help treat GNAQ-mutant uveal melanoma. Levels
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury